Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-03-06 @ 9:23 PM
Study NCT ID:
NCT03427060
Status:
COMPLETED
Last Update Posted:
2025-05-04
First Post:
2018-01-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Sponsor:
AKARI Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AK585
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None